Epigenetic deregulation of the COX pathway in cancer

Progress in Lipid Research

Volumn 51, Issue 4, 2012, Pages 301-313

  Cebola, Inês ^a   Peinado, Miguel A ^a  

^a Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

Author keywords

DNA methylation; Gene regulation; Gene silencing; Histone modification; Inflammation and cancer; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LIPOCALIN TYPE PGD2 SYNTHETASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; UNCLASSIFIED DRUG;

APOPTOSIS; BIOSYNTHESIS; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; DRUG TARGETING; ENZYME REGULATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; HUMAN; INFLAMMATION; LIPOGENESIS; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

DINOPROST; DINOPROSTONE; EPIGENESIS, GENETIC; EPOPROSTENOL; GENE SILENCING; HUMANS; NEOPLASMS; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; THROMBOXANE A2;

EID: 84861608191     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2012.02.005     Document Type: Review

References (249)

1. R.A. Woutersen, M.J. Appel, A. van Garderen-Hoetmer, and M.V. Wijnands Dietary fat and carcinogenesis Mutat Res 443 1999 111 127
2. E.R. Greene, S. Huang, C.N. Serhan, and D. Panigrahy Regulation of inflammation in cancer by eicosanoids Prostaglandins Other Lipid Mediators 96 2011 27 36
3. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat Rev Cancer 10 2010 181 193
4. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. Dubois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
5. A. Ristimäki, N. Honkanen, H. Jänkälä, P. Sipponen, and M. Härkönen Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res 57 1997 1276 1280
6. H. Wolff, K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio, and A. Ristimäki Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 1998 4997 5001
7. X.H. Liu, and D.P. Rose Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines Cancer Res 56 1996 5125 5127
8. N. Zidar, K. Odar, D. Glavac, M. Jerse, T. Zupanc, and D. Stajer Cyclooxygenase in normal human tissues: is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med 13 2009 3753 3763
9. A.K. Bauer, L.D. Dwyer-Nield, and A.M. Malkinson High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors Carcinogenesis 21 2000 543 550
10. J.T. Nurmi, P.A. Puolakkainen, and N.E. Rautonen Intron 1 retaining cyclooxygenase 1 splice variant is induced by osmotic stress in human intestinal epithelial cells Prostaglandins Leukotrienes Essent Fatty Acids 73 2005 343 350
11. S. Chell, A. Kaidi, A.C. Williams, and C. Paraskeva Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer Biochim Biophys Acta 1766 2006 104 119
12. S.M. Prescott, and F.A. Fitzpatrick Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470 2000 M69 M78
13. R.Y. Huang, and G.G. Chen Cigarette smoking, cyclooxygenase-2 pathway and cancer Biochim Biophys Acta 1815 2011 158 169
14. S.Y. Buckman, A. Gresham, P. Hale, G. Hruza, J. Anast, and J. Masferrer COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer Carcinogenesis 19 1998 723 729
15. K.H. Weylandt, L.F. Krause, B. Gomolka, C.-Y. Chiu, S. Bilal, and A. Nadolny Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-{alpha} Carcinogenesis 2011
16. D.R. Walker, J.P. Bond, R.E. Tarone, C.C. Harris, W. Makalowski, and M.S. Boguski Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features Oncogene 18 1999 211 218
17. H. Funahashi, M. Satake, S. Hasan, H. Sawai, R.A. Newman, and H.A. Reber Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth Pancreas 36 2008 353 362
18. A. Angelucci, S. Garofalo, S. Speca, A. Bovadilla, G.L. Gravina, and P. Muzi Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells Endocr Relat Cancer 15 2008 91 100
19. M. Hughes-Fulford, Y. Chen, and R.R. Tjandrawinata Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells Carcinogenesis 22 2001 701 707
20. D.P. Rose, and J.M. Connolly Omega-3 fatty acids as cancer chemopreventive agents Pharmacol Ther 83 1999 217 244
21. Y.-W.E. Chang, K. Putzer, L. Ren, B. Kaboord, T.W. Chance, and M.W. Qoronfleh Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA J Cell Biochem 96 2005 314 329
22. R.J. Coffey, C.J. Hawkey, L. Damstrup, R. Graves-Deal, V.C. Daniel, and P.J. Dempsey Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells Proc Natl Acad Sci U S A 94 1997 657 662
23. D. Moraitis, B. Du, M.S. De Lorenzo, J.O. Boyle, B.B. Weksler, and E.G. Cohen Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands Cancer Res 65 2005 664 670
24. J.R. Reed, R.P. Leon, M.K. Hall, and K.L. Schwertfeger Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis Breast Cancer Res 11 2009 R21
25. K.-Y. Chang, M.-R. Shen, M.-Y. Lee, W.-L. Wang, W.-C. Su, and W.-C. Chang Epidermal growth factor-activated aryl hydrocarbon receptor nuclear translocator/HIF-1{beta} signal pathway up-regulates cyclooxygenase-2 gene expression associated with squamous cell carcinoma J Biol Chem 284 2009 9908 9916
26. D. Saha, P.K. Datta, H. Sheng, J.D. Morrow, M. Wada, and H.L. Moses Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells Neoplasia 1 1999 508 517
27. W. Liu, N. Reinmuth, O. Stoeltzing, A.A. Parikh, C. Tellez, and S. Williams Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways Cancer Res 63 2003 3632 3636
28. P.C. Konturek, A. Hartwich, M. Zuchowicz, H. Labza, P. Pierzchalski, and E. Karczewska Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer J Physiol Pharmacol 51 2000 737 749
29. Y.J. Chang, M.S. Wu, J.T. Lin, B.S. Sheu, T. Muta, and H. Inoue Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation Mol Pharmacol 66 2004 1465 1477
30. M.M.M. Abdel-Latif, H. Windle, A. Terres, D.N. Eidhin, D. Kelleher, and J.V. Reynolds Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells J Gastrointest Surg 10 2006 551 562
31. A. Singh, H. Sharma, S. Salhan, S.D. Gupta, N. Bhatla, and S.K. Jain Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer Pathobiology 71 2004 314 322
32. A.S.-L. Cheng, H.L.-Y. Chan, W.K. Leung, K.F. To, M.Y.-Y. Go, and J.Y.-H. Chan Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2 Mod Pathol 17 2004 1169 1179
33. R. Kaul, S.C. Verma, M. Murakami, K. Lan, T. Choudhuri, and E.S. Robertson Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 J Virol 80 2006 1321 1331
34. E. Lara-Pezzi, M.V. Gómez-Gaviro, B.G. Gálvez, E. Mira, M.A. Iñiguez, and M. Fresno The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression J Clin Invest 110 2002 1831 1838
35. G. Waris, and A. Siddiqui Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication J Virol 79 2005 9725 9734
36. S. Murono, H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, and M. Furukawa Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci U S A 98 2001 6905 6910
37. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
38. S. Battu, M. Rigaud, and J.L. Beneytout Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29 CL.19A Anticancer Res 18 1998 3579 3583
39. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 1995 493 501
40. X. Tang, Y.J. Sun, E. Half, M.T. Kuo, and F. Sinicrope Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells Cancer Res 62 2002 4903 4908
41. G. Totzke, K. Schulze-Osthoff, and R.U. Jänicke Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition Oncogene 22 2003 8021 8030
42. Y. Yamanaka, K. Shiraki, T. Inoue, K. Miyashita, H. Fuke, and Y. Yamaguchi COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis Int J Mol Med 18 2006 41 47
43. S. Martin, D.C. Phillips, K. Szekely-Szucs, L. Elghazi, F. Desmots, and J.A. Houghton Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae Cancer Res 65 2005 11447 11458
44. B.A. Pockaj, G.D. Basu, L.B. Pathangey, R.J. Gray, J.L. Hernandez, and S.J. Gendler Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer Ann Surg Oncol 11 2004 328 339
45. R. Pai, B. Soreghan, I.L. Szabo, M. Pavelka, D. Baatar, and A.S. Tarnawski Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat Med 8 2002 289 293
46. T. Kinoshita, Y. Takahashi, T. Sakashita, H. Inoue, T. Tanabe, and T. Yoshimoto Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells Biochim Biophys Acta 1438 1999 120 130
47. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and E.R. Simpson Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 1996 5739 5742
48. M.D. Castellone, H. Teramoto, B.O. Williams, K.M. Druey, and J.S. Gutkind Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 2005 1504 1510
49. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, and V. Boddi Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. implications for tumor angiogenesis and metastasis Neoplasia 3 2001 53 61
50. J.L. Masferrer, K.M. Leahy, A.T. Koki, B.S. Zweifel, S.L. Settle, and B.M. Woerner Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 2000 1306 1311
51. W.K. Leung, K.F. To, M.Y.Y. Go, K.-K. Chan, F.K.L. Chan, and E.K.W. Ng Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma Int J Oncol 23 2003 1317 1322
52. W.H. Sun, Y.L. Sun, R.N. Fang, Y. Shao, H.C. Xu, and Q.P. Xue Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis Jpn J Clin Oncol 35 2005 707 713
53. M. Tsujii, S. Kawano, and R.N. DuBois Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci U S A 94 1997 3336 3340
54. A. Sivula, A. Talvensaari-Mattila, J. Lundin, H. Joensuu, C. Haglund, and A. Ristimäki Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer Breast Cancer Res Treat 89 2005 215 220
55. J.H. Byun, M.A. Lee, S.Y. Roh, B.Y. Shim, S.H. Hong, and Y.H. Ko Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer Jpn J Clin Oncol 36 2006 263 268
56. T.L. Larkins, M. Nowell, S. Singh, and G.L. Sanford Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression BMC Cancer 6 2006 181
57. Y. Kinugasa, M. Hatori, H. Ito, Y. Kurihara, D. Ito, and M. Nagumo Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44 Clin Exp Metastasis 21 2004 737 745
58. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, and E. Kwong Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
59. P.C. Chulada, M.B. Thompson, J.F. Mahler, C.M. Doyle, B.W. Gaul, and C. Lee Genetic disruption of PTGS-1, as well as PTGS-2, reduces intestinal tumorigenesis in Min mice Cancer Res 60 2000 4705 4708
60. T. Tanaka, H. Kohno, R. Suzuki, Y. Yamada, S. Sugie, and H. Mori A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate Cancer Sci 94 2003 965 973
61. R.E. Harris Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung Inflammopharmacology 17 2009 55 67
62. N. Arber, and B. Levin Chemoprevention of colorectal neoplasia: the potential for personalized medicine Gastroenterology 134 2008 1224 1237
63. A.T. Chan, and E.L. Giovannucci Primary prevention of colorectal cancer Gastroenterology 138 2029-43 2010 e10
64. F.M. Giardiello Sulindac and polyp regression Cancer Metastasis Rev 13 1994 279 283
65. T.D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J.A. Mitchell, and J.R. Vane Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis Proc Natl Acad Sci U S A 96 1999 7563 7568
66. P. Patrignani, M.L. Capone, and S. Tacconelli NSAIDs and cardiovascular disease Heart 94 2008 395 397
67. E. Arehart, J. Stitham, F.W. Asselbergs, K. Douville, T. MacKenzie, and K.M. Fetalvero Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition Circ Res 102 2008 986 993
68. U. Vogel, J. Christensen, H. Wallin, S. Friis, B.A. Nexo, and O. Raaschou-Nielsen Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study Mutat Res 639 2008 89 100
69. I. Tegeder, J. Pfeilschifter, and G. Geisslinger Cyclooxygenase- independent actions of cyclooxygenase inhibitors FASEB J 15 2001 2057 2072
70. F.V.N. Din, M.G. Dunlop, and L.A. Stark Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis Br J Cancer 91 2004 381 388
71. A.D. Goldberg, C.D. Allis, and E. Bernstein Epigenetics: a landscape takes shape Cell 128 2007 635 638
72. M. Esteller Cancer epigenomics: DNA methylomes and histone-modification maps Nat Rev Genet 8 2007 286 298
73. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
74. G. Felsenfeld, and M. Groudine Controlling the double helix Nature 421 2003 448 453
75. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat Biotechnol 28 2010 1057 1068
76. A. Bird DNA methylation patterns and epigenetic memory Genes Dev 16 2002 6 21
77. M.G. Goll, and T.H. Bestor Eukaryotic cytosine methyltransferases Annu Rev Biochem 74 2005 481 514
78. P.A. Jones, and D. Takai The role of DNA methylation in mammalian epigenetics Science 293 2001 1068 1070
79. R. Jaenisch, and A. Bird Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nat Genet 33 Suppl 2003 245 254
80. B.E. Bernstein, J.A. Stamatoyannopoulos, J.F. Costello, B. Ren, A. Milosavljevic, and A. Meissner The NIH roadmap epigenomics mapping consortium Nat Biotechnol 28 2010 1045 1048
81. A.P. Feinberg Phenotypic plasticity and the epigenetics of human disease Nature 447 2007 433 440
82. R.A. Irizarry, C. Ladd-Acosta, B. Wen, Z. Wu, C. Montano, and P. Onyango The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores Nat Genet 41 2009 178 186
83. A. Doi, I.H. Park, B. Wen, P. Murakami, M.J. Aryee, and R. Irizarry Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts Nat Genet 2009
84. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2004 143 153
85. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2003 2042 2054
86. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
87. M. Ehrlich DNA methylation in cancer: too much, but also too little Oncogene 21 2002 5400 5413
88. A.J. Bannister, and T. Kouzarides Regulation of chromatin by histone modifications Cell Res 21 2011 381 395
89. T. Kouzarides Chromatin modifications and their function Cell 128 2007 693 705
90. B.E. Bernstein, T.S. Mikkelsen, X. Xie, M. Kamal, D.J. Huebert, and J. Cuff A bivalent chromatin structure marks key developmental genes in embryonic stem cells Cell 125 2006 315 326
91. M.J. Barrero, S. Boue, and J.C. Izpisua Belmonte Epigenetic mechanisms that regulate cell identity Cell Stem Cell 7 2010 565 570
92. M. Widschwendter, H. Fiegl, D. Egle, E. Mueller-Holzner, G. Spizzo, and C. Marth Epigenetic stem cell signature in cancer Nat Genet 39 2007 157 158
93. J.E. Ohm, K.M. McGarvey, X. Yu, L. Cheng, K.E. Schuebel, and L. Cope A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing Nat Genet 39 2007 237 242
94. J. Rodriguez, M. Muñoz, L. Vives, C.G. Frangou, M. Groudine, and M.A. Peinado Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells Proc Natl Acad Sci U S A 105 2008 19809 19814
95. M. Toyota, L. Shen, M. Ohe-Toyota, S.R. Hamilton, F.A. Sinicrope, and J.P. Issa Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors Cancer Res 60 2000 4044 4048
96. S.H. Song, H.S. Jong, H.H. Choi, H. Inoue, T. Tanabe, and N.K. Kim Transcriptional silencing of cyclooxygenase-2 by hyper-methylation of the 5′ CpG island in human gastric carcinoma cells Cancer Res 61 2001 4628 4635
97. J.C. Kim, J.S. Choi, S.A. Roh, D.H. Cho, T.W. Kim, and Y.S. Kim Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas Ann Surg Oncol 17 2010 1767 1776
98. A.G. Asting, H. Caren, M. Andersson, C. Lonnroth, K. Lagerstedt, and K. Lundholm COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status BMC Cancer 11 2011 238
99. T. Kikuchi, F. Itoh, M. Toyota, H. Suzuki, H. Yamamoto, and M. Fujita Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer Int J Cancer 97 2002 272 277
100. X. Ma, Q. Yang, K.T. Wilson, N. Kundu, S.J. Meltzer, and A.M. Fulton Promoter methylation regulates cyclooxygenase expression in breast cancer Breast Cancer Res 6 2004 R316 R321
101. L.W.C. Chow, L. Zhu, W.T.Y. Loo, and E.L.H. Lui Aberrant methylation of cyclooxygenase-2 in breast cancer patients Biomed Pharmacother 59 Suppl 2 2005 S264 S267
102. H. Murata, S. Tsuji, M. Tsujii, Y. Sakaguchi, H.Y. Fu, and S. Kawano Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells Lab Invest 84 2004 1050 1059
103. N. Nishida, T. Nagasaka, T. Nishimura, I. Ikai, C.R. Boland, and A. Goel Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma Hepatology 47 2008 908 918
104. T.H. Um, H. Kim, B.K. Oh, M.S. Kim, K.S. Kim, and G. Jung Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis J Hepatol 54 2011 939 947
105. R. Soo, T. Putti, Q. Tao, B.-C. Goh, K.-H. Lee, and L. Kwok-Seng Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression Arch Otolaryngol Head Neck Surg 131 2005 147 152
106. P.J. Bastian, J. Ellinger, L.C. Heukamp, P. Kahl, S.C. Müller, and A. von Rücker Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy Eur Urol 51 2007 665 674
107. D. Lodygin, A. Epanchintsev, A. Menssen, J. Diebold, and H. Hermeking Functional epigenomics identifies genes frequently silenced in prostate cancer Cancer Res 65 2005 4218 4227
108. S.P. Dawsey, M.J. Roth, L. Adams, N. Hu, Q.-H. Wang, and P.R. Taylor COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia Cancer Detect Prev 32 2008 135 139
109. X.Y. Meng, S.T. Zhu, Y. Zong, Y.J. Wang, P. Li, and S.T. Zhang Promoter hypermethylation of cyclooxygenase-2 gene in esophageal squamous cell carcinoma Dis Esophagus 24 2011 444 449
110. N. Omura, M. Griffith, A. Vincent, A. Li, S.-M. Hong, and K. Walter Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins Mol Cancer Res 8 2010 821 832
111. K. Subbaramaiah, and A.J. Dannenberg Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange Cancer Res 67 2007 3976 3985
112. S. Kulkarni, J.S. Rader, F. Zhang, H. Liapis, A.T. Koki, and J.L. Masferrer Cyclooxygenase-2 is overexpressed in human cervical cancer Clin Cancer Res 7 2001 429 434
113. H.S. Ryu, K.H. Chang, H.W. Yang, M.S. Kim, H.C. Kwon, and K.S. Oh High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion Gynecol Oncol 76 2000 320 325
114. A.M. Kalle, S. Sachchidanand, and R. Pallu Bcr-Abl-independent mechanism of resistance to imatinib in K562 cells: induction of cyclooxygenase-2 (COX-2) by histone deacetylases (HDACs) Leuk Res 34 2010 1132 1138
115. X. Tong, L. Yin, S. Joshi, D.W. Rosenberg, and C. Giardina Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors J Biol Chem 280 2005 15503 15509
116. D.E. Stange, B. Radlwimmer, F. Schubert, F. Traub, A. Pich, and G. Toedt High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer Clin Cancer Res 12 2006 345 352
117. S. Fu, K.S. Ramanujam, A. Wong, G.T. Fantry, C.B. Drachenberg, and S.P. James Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis Gastroenterology 116 1999 1319 1329
118. M. Akhtar, Y. Cheng, R.M. Magno, H. Ashktorab, D.T. Smoot, and S.J. Meltzer Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells Cancer Res 61 2001 2399 2403
119. R. Pero, S. Peluso, T. Angrisano, C. Tuccillo, S. Sacchetti, and S. Keller Chromatin and DNA methylation dynamics of Helicobacter pylori-induced COX-2 activation Int J Med Microbiol 301 2011 140 149
120. M.F.G. de Maat, C.J.H. van de Velde, N. Umetani, P. de Heer, H. Putter, and A.Q. van Hoesel Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer J Clin Oncol 25 2007 4887 4894
121. P. Ulivi, L. Mercatali, W. Zoli, D. Dell'amore, V. Poletti, and G.L. Casoni Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection Thorax 63 2008 843 844
122. S. Kanaoka, K. Yoshida, N. Miura, H. Sugimura, and M. Kajimura Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening Gastroenterology 127 2004 422 427
123. W.K. Leung, K.-F. To, E.P.S. Man, M.W.Y. Chan, A.J. Hui, and S.S.M. Ng Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps Am J Gastroenterol 102 2007 1070 1076
124. Y. Edden, S.D. Wexner, and M. Berho The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma Colorectal Dis 2011
125. A. Greenhough, H.J.M. Smartt, A.E. Moore, H.R. Roberts, A.C. Williams, and C. Paraskeva The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 2009 377 386
126. B. Rigas, I.S. Goldman, and L. Levine Altered eicosanoid levels in human colon cancer J Lab Clin Med 122 1993 518 523
127. S. Pugh, and G.A. Thomas Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2 Gut 35 1994 675 678
128. K.-T. Kuo, H.-W. Wang, T.-Y. Chou, W.-H. Hsu, H.-S. Hsu, and C.-H. Lin Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma Ann Surg Oncol 16 2009 352 360
129. M. Hambek, M. Baghi, J. Wagenblast, J. Schmitt, H. Baumann, and R. Knecht Inverse correlation between serum PGE2 and T classification in head and neck cancer Head Neck 29 2007 244 248
130. T. Kawamori, N. Uchiya, T. Sugimura, and K. Wakabayashi Enhancement of colon carcinogenesis by prostaglandin E2 administration Carcinogenesis 24 2003 985 990
131. M.B. Hansen-Petrik, M.F. McEntee, B. Jull, H. Shi, M.B. Zemel, and J. Whelan Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice Cancer Res 62 2002 403 408
132. D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis J Biol Chem 278 2003 19396 19405
133. K. Yoshimatsu, N.K. Altorki, D. Golijanin, F. Zhang, P.J. Jakobsson, and A.J. Dannenberg Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer Clin Cancer Res 7 2001 2669 2674
134. K. Yoshimatsu, D. Golijanin, P.B. Paty, R.A. Soslow, P.J. Jakobsson, and R.A. DeLellis Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer Clin Cancer Res 7 2001 3971 3976
135. K. Gudis, A. Tatsuguchi, K. Wada, T. Hiratsuka, S. Futagami, and Y. Fukuda Clinical significance of prostaglandin E synthase expression in gastric cancer tissue Hum Pathol 38 2007 1826 1835
136. S. Hasan, M. Satake, D.W. Dawson, H. Funahashi, E. Angst, and V.L.W. Go Expression analysis of the prostaglandin E2 production pathway in human pancreatic cancers Pancreas 37 2008 121 127
137. M. Herfs, L. Herman, P. Hubert, F. Minner, M. Arafa, and P. Roncarati High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells Cancer Immunol Immunother 58 2009 603 614
138. H. Hanaka, S.-C. Pawelzik, J.I. Johnsen, M. Rakonjac, K. Terawaki, and A. Rasmuson Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells Proc Natl Acad Sci U S A 106 2009 18757 18762
139. Y. Omi, N. Shibata, T. Okamoto, T. Obara, and M. Kobayashi Immunohistochemical demonstration of membrane-bound prostaglandin E2 synthase-1 in papillary thyroid carcinoma Acta Histochem Cytochem 42 2009 105 109
140. N. Baryawno, B. Sveinbjörnsson, S. Eksborg, A. Orrego, L. Segerström, and C.O. Oqvist Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets Neuro-oncol 10 2008 661 674
141. S. Mattila, H. Tuominen, J. Koivukangas, and F. Stenbäck The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas Neuropathology 29 2009 156 165
142. R. Kawata, S. Hyo, M. Araki, and H. Takenaka Expression of cyclooxygenase-2 and microsomal prostagalandin E synthase-1 in head and neck squamous cell carcinoma Auris Nasus Larynx 37 2010 482 487
143. M. Camacho, X. León, M.-T. Fernández-Figueras, M. Quer, and L. Vila Prostaglandin E(2) pathway in head and neck squamous cell carcinoma Head Neck 30 2008 1175 1181
144. M. Nakanishi, D.C. Montrose, P. Clark, P.R. Nambiar, G.S. Belinsky, and K.P. Claffey Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis Cancer Res 68 2008 3251 3259
145. Y. Sasaki, D. Kamei, Y. Ishikawa, T. Ishii, S. Uematsu, and S. Akira Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis Oncogene 2011
146. H. Fan, Z. Zhao, Y. Quan, J. Xu, J. Zhang, and W. Xie DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721 Eur J Gastroenterol Hepatol 19 2007 952 961
147. M. Alaa, M. Suzuki, M. Yoshino, L. Tian, H. Suzuki, and K. Nagato Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis Int J Oncol 34 2009 805 812
148. Y. Baba, K. Nosho, K. Shima, W. Goessling, A.T. Chan, and K. Ng PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype Cancer Epidemiol Biomarkers Prev 19 2010 822 831
149. K.-S. Chun, H.-C. Lao, C.S. Trempus, M. Okada, and R. Langenbach The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development Carcinogenesis 30 2009 1620 1627
150. A.G. Paul, N. Sharma-Walia, N. Kerur, C. White, and B. Chandran Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen Cancer Res 70 2010 3697 3708
151. Y. Sugino, A. Misawa, J. Inoue, M. Kitagawa, H. Hosoi, and T. Sugimoto Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas Oncogene 26 2007 7401 7413
152. L. Tian, M. Suzuki, T. Nakajima, R. Kubo, Y. Sekine, and K. Shibuya Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation Cancer 113 2008 1396 1403
153. S.G. Gray, N. Al-Sarraf, A.-M. Baird, M.-C. Cathcart, E. McGovern, and K.J. O'Byrne Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications Eur J Cancer 45 2009 3087 3097
154. Y. Zhang, and Y. Daaka PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway Blood 118 2011 5355 5364
155. Y. Shoji, M. Takahashi, T. Kitamura, K. Watanabe, T. Kawamori, and T. Maruyama Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development Gut 53 2004 1151 1158
156. M.G. Backlund, J.R. Mann, V.R. Holla, F.G. Buchanan, H.H. Tai, and E.S. Musiek 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer J Biol Chem 280 2005 3217 3223
157. A. Leslie, A. Stewart, D.U. Baty, D. Mechan, L. McGreavey, and G. Smith Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility Genes Chromosomes Cancer 45 2006 126 135
158. T.J. Jang, Y.S. Ji, and K.H. Jung Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas Yonsei Med J 49 2008 917 922
159. D. Hughes, T. Otani, P. Yang, R.A. Newman, R.K. Yantiss, and N.K. Altorki NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer Cancer Prev Res (Phila) 1 2008 241 249
160. A. Thiel, A. Ganesan, J. Mrena, S. Junnila, A. Nykänen, and A. Hemmes 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer Clin Cancer Res 15 2009 4572 4580
161. H.K. Na, J.M. Park, H.G. Lee, H.N. Lee, S.J. Myung, and Y.J. Surh 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy Biochem Pharmacol 82 2011 1352 1360
162. M.G. Backlund, J.R. Mann, V.R. Holla, Q. Shi, T. Daikoku, and S.K. Dey Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer Cancer Res 68 2008 9331 9337
163. M. Tong, Y. Ding, and H.-H. Tai Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells Biochem Pharmacol 72 2006 701 709
164. A.E. Moore, L.E. Young, and D.A. Dixon MicroRNA and AU-rich element regulation of prostaglandin synthesis Cancer metastasis rev 2011
165. N. Iwai, T. Katsuya, K. Ishikawa, T. Mannami, J. Ogata, and J. Higaki Human prostacyclin synthase gene and hypertension: the Suita study Circulation 100 1999 2231 2236
166. G.A. FitzGerald, A.K. Pedersen, and C. Patrono Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease Circulation 67 1983 1174 1177
167. M. Camacho, C. Rodriguez, A. Guadall, S. Alcolea, M. Orriols, and J.R. Escudero Hypoxia upregulates PGI-synthase and increases PGI release in human vascular cells exposed to inflammatory stimuli J Lipid Res 52 2011 720 731
168. T. Hatae, M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe Prostacyclin-dependent apoptosis mediated by PPAR delta J Biol Chem 276 2001 46260 46267
169. R.L. Keith, Y.E. Miller, Y. Hoshikawa, M.D. Moore, T.L. Gesell, and B. Gao Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer Cancer Res 62 2002 734 740
170. R.L. Keith, V. Karoor, A.B. Mozer, T.M. Hudish, M. Le, and Y.E. Miller Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression Lung Cancer 70 2010 37 42
171. R.L. Keith, Y.E. Miller, T.M. Hudish, C.E. Girod, S. Sotto-Santiago, and W.A. Franklin Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice Cancer Res 64 2004 5897 5904
172. R. Nemenoff, A.M. Meyer, T.M. Hudish, A.B. Mozer, A. Snee, and S. Narumiya Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator-activated receptor gamma Cancer Prev Res (Phila) 1 2008 349 356
173. R.-C. Li, T. Cindrova-Davies, J.N. Skepper, and L.A. Sellers Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor Circ Res 94 2004 759 767
174. E.M. Poole, J. Bigler, J. Whitton, J.G. Sibert, J.D. Potter, and C.M. Ulrich Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps Cancer Epidemiol Biomarkers Prev 15 2006 502 508
175. J.E. Abraham, P. Harrington, K.E. Driver, J. Tyrer, D.F. Easton, and A.M. Dunning Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival Clin Cancer Res 15 2009 2181 2191
176. N.S. Cutler, R. Graves-Deal, B.J. LaFleur, Z. Gao, B.M. Boman, and R.H. Whitehead Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells Cancer Res 63 2003 1748 1751
177. J. Frigola, M. Muñoz, S.J. Clark, V. Moreno, G. Capella, and M.A. Peinado Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy Oncogene 24 2005 7320 7326
178. R.S. Stearman, M.C. Grady, P. Nana-Sinkam, M. Varella-Garcia, and M.W. Geraci Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines Mol Cancer Res 5 2007 295 308
179. M.C. Cathcart, S.G. Gray, A.M. Baird, E. Boyle, K. Gately, and E. Kay Prostacyclin synthase expression and epigenetic regulation in nonsmall cell lung cancer Cancer 2011
180. J. Chen, C. Röcken, L. Klein-Hitpass, T. Götze, A. Leodolter, and P. Malfertheiner Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2′-deoxycytidine Clin Exp Metastasis 21 2004 389 397
181. R.A. Gupta, J. Tan, W.F. Krause, M.W. Geraci, T.M. Willson, and S.K. Dey Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer Proc Natl Acad Sci U S A 97 2000 13275 13280
182. E. Falcetti, D.M. Flavell, B. Staels, A. Tinker, S.G. Haworth, and L.H. Clapp IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues Biochem Biophys Res Commun 360 2007 821 827
183. L. Yang, Z.-G. Zhou, X.-L. Zheng, L. Wang, Y.-Y. Yu, and B. Zhou RNA interference against peroxisome proliferator-activated receptor delta gene promotes proliferation of human colorectal cancer cells Dis Colon Rectum 51 2008 318 326
184. K. Tachibana, D. Yamasaki, K. Ishimoto, and T. Doi The Role of PPARs in Cancer PPAR Res 2008 2008 102737
185. M. Ghosh, Y. Ai, K. Narko, Z. Wang, J.M. Peters, and T. Hla PPARdelta is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer Prostaglandins Other Lipid Mediat 88 2009 97 100
186. S. Ogino, K. Shima, Y. Baba, K. Nosho, N. Irahara, and S. Kure Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis Gastroenterology 136 2009 1242 1250
187. M. Pancione, L. Sabatino, A. Fucci, V. Carafa, A. Nebbioso, and N. Forte Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome PLoS One 5 2010 e14229
188. Y. Urade, and O. Hayaishi Prostaglandin D synthase: structure and function Vitam Horm 58 2000 89 120
189. Y. Urade, and N. Eguchi Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence Prostaglandins Other Lipid Mediat 68-69 2002 375 382
190. D.N. Melegos, and E.P. Diamandis Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer Clin Biochem 29 1996 193 200
191. L. Saso, M.G. Leone, C. Sorrentino, S. Giacomelli, B. Silvestrini, and J. Grima Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor Biochem Mol Biol Int 46 1998 643 656
192. B. Su, M. Guan, R. Zhao, and Y. Lu Expression of prostaglandin D synthase in ovarian cancer Clin Chem Lab Med 39 2001 1198 1203
193. C.A. Payne, S. Maleki, M. Messina, M.G. O'Sullivan, G. Stone, and N.R. Hall Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma Mol Cancer Ther 7 2008 3420 3428
194. L. Ragolia, T. Palaia, C.E. Hall, J. Klein, and A. Büyük Diminished lipocalin-type prostaglandin D(2) synthase expression in human lung tumors Lung Cancer 70 2010 103 109
195. C.L. Bos, D.J. Richel, T. Ritsema, M.P. Peppelenbosch, and H.H. Versteeg Prostanoids and prostanoid receptors in signal transduction Int J Biochem Cell Biol 36 2004 1187 1205
196. F.G. Gervais, R.P. Cruz, A. Chateauneuf, S. Gale, N. Sawyer, and F. Nantel Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP J Allergy Clin Immunol 108 2001 982 988
197. T. Murata, M.I. Lin, K. Aritake, S. Matsumoto, S. Narumiya, and H. Ozaki Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo Proc Natl Acad Sci U S A 105 2008 20009 20014
198. H. Hirai, K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, and Y. Takamori Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J Exp Med 193 2001 255 261
199. A. Gustafsson, E. Hansson, U. Kressner, S. Nordgren, M. Andersson, and C. Lonnroth Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression Acta Oncol 46 2007 1107 1112
200. G. Hawcroft, S.H. Gardner, and M.A. Hull Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells Cancer Lett 210 2004 81 84
201. B. Sadikovic, M. Yoshimoto, K. Al-Romaih, G. Maire, M. Zielenska, and J.A. Squire In vitro analysis of integrated global high-resolution DNA methylation profiling with genomic imbalance and gene expression in osteosarcoma PLoS One 3 2008 e2834
202. S. Kajita, K.H. Ruebel, M.B. Casey, N. Nakamura, and R.V. Lloyd Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth Mod Pathol 18 2005 221 227
203. O. Moussa, J.S. Yordy, H. Abol-Enein, D. Sinha, N.K. Bissada, and P.V. Halushka Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer Cancer Res 65 2005 11581 11587
204. T. Dassesse, X. de Leval, L. de Leval, B. Pirotte, V. Castronovo, and D. Waltregny Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage Eur Urol 50 2006 1021 1031
205. H. Sakai, T. Suzuki, Y. Takahashi, M. Ukai, K. Tauchi, and T. Fujii Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2 FEBS Lett 580 2006 3368 3374
206. K.D. Lee, S.J. Baek, and R.F. Shen Multiple factors regulating the expression of human thromboxane synthase gene Biochem J 319 Pt 3 1996 783 791
207. G. Watkins, A. Douglas-Jones, R.E. Mansel, and W.G. Jiang Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer Int Semin Surg Oncol 2 2005 23
208. M.F. Paz, S. Wei, J.C. Cigudosa, S. Rodriguez-Perales, M.A. Peinado, and T.H. Huang Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases Hum Mol Genet 12 2003 2209 2219
209. Z. Kabututu, M. Manin, J.-C. Pointud, T. Maruyama, N. Nagata, and S. Lambert Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7 J Biochem (Tokyo) 145 2009 161 168
210. D. Wölfle Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F(2 alpha) Toxicology 188 2003 139 147
211. D. Qualtrough, A. Kaidi, S. Chell, H.N. Jabbour, A.C. Williams, and C. Paraskeva Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells Int J Cancer 121 2007 734 740
212. K. Watanabe Prostaglandin F Synthase Prostaglandins Other Lipid Mediat 68-69 2002 401 407
213. S. Nigam, A. Zakrzewicz, S. Eskafi, and A. Roscher Clinical significance of prostacyclin and thromboxane in cancer of the female breast and genital tract Cancer Metastasis Rev 11 1992 411 420
214. E. Bresson, S. Boucher-Kovalik, P. Chapdelaine, E. Madore, N. Harvey, and P.Y. Laberge The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium J Clin Endocrinol Metab 96 2011 210 219
215. C.-S. Liao, P.-J. Tai, Y.-H. Huang, R.-N. Chen, S.-M. Wu, and L.-W. Kuo Regulation of AKR1B1 by thyroid hormone and its receptors Mol Cell Endocrinol 307 2009 109 117
216. A.-M. Lefrançois-Martinez, J. Bertherat, P. Val, C. Tournaire, N. Gallo-Payet, and D. Hyndman Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors J Clin Endocrinol Metab 89 2004 3010 3019
217. E.S. Kropotova, R.A. Tychko, O.L. Zinov'eva, A.F. Zyrianova, S.L. Khankin, and V.L. Cherkes Downregulation of AKR1B10 gene expression in colorectal cancer Mol Biol (Mosk) 44 2010 243 250
218. K.J. Sales, D. Maldonado-Pérez, V. Grant, R.D. Catalano, M.R. Wilson, and P. Brown Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway Biochim Biophys Acta 1793 2009 1917 1928
219. I. Keshet, Y. Schlesinger, S. Farkash, E. Rand, M. Hecht, and E. Segal Evidence for an instructive mechanism of de novo methylation in cancer cells Nat Genet 38 2006 149 153
220. K. Sossey-Alaoui, E. Kitamura, and J.K. Cowell Fine mapping of the PTGFR gene to 1p31 region and mutation analysis in human breast cancer Int J Mol Med 7 2001 543 546
221. R.M. Breyer, C.K. Bagdassarian, S.A. Myers, and M.D. Breyer Prostanoid receptors: subtypes and signaling Annu Rev Pharmacol Toxicol 41 2001 661 690
222. C.M. Ulrich, J. Bigler, R. Sparks, J. Whitton, J.G. Sibert, and E.L. Goode Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps Cancer Epidemiol Biomarkers Prev 13 2004 889 893
223. B. Frank, M. Hoffmeister, N. Klopp, T. Illig, J. Chang-Claude, and H. Brenner Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk Int J Cancer 127 2010 2822 2830
224. S. Küry, B. Buecher, S. Robiou-du-Pont, C. Scoul, H. Colman, and T. Le Neel Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study BMC Cancer 8 2008 326
225. L.C. Sakoda, Y.-T. Gao, B.E. Chen, J. Chen, P.S. Rosenberg, and A. Rashid Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China Carcinogenesis 27 2006 1251 1256
226. F. Li, G.S. Ren, H.Y. Li, X.Y. Wang, L. Chen, and J. Li A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer Clin Oncol (R Coll Radiol) 21 2009 302 305
227. S. Schonfeld, P. Bhatti, E.E. Brown, M.S. Linet, S.L. Simon, and R.M. Weinstock Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists Cancer Causes Control 21 2010 1857 1866
228. L. Dossus, R. Kaaks, F. Canzian, D. Albanes, S.I. Berndt, and H. Boeing PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3) Carcinogenesis 31 2010 455 461
229. U. Langsenlehner, B. Yazdani-Biuki, T. Eder, W. Renner, T.C. Wascher, and B. Paulweber The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk Clin Cancer Res 12 2006 1392 1394
230. H. Yang, J. Gu, X. Lin, H.B. Grossman, Y. Ye, and C.P. Dinney Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition Clin Cancer Res 14 2008 2236 2244
231. C.L.E. Siezen, H.B. Bueno-de-Mesquita, P.H.M. Peeters, N.R. Kram, M. van Doeselaar, and H.J. van Kranen Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer Int J Cancer 119 2006 297 303
232. D.G. Cox, C. Pontes, E. Guino, M. Navarro, A. Osorio, and F. Canzian Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer Br J Cancer 91 2004 339 343
233. T. Kawasaki, K. Nosho, M. Ohnishi, Y. Suemoto, G.J. Kirkner, and R. Dehari Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer Neoplasia 9 2007 569 577
234. S. Ogino, G.J. Kirkner, K. Nosho, N. Irahara, S. Kure, and K. Shima Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer Clin Cancer Res 14 2008 8221 8227
235. K. Srivastava, A. Srivastava, A. Kumar, and B. Mittal Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes PLoS One 6 2011 e16449
236. K. Srivastava, A. Srivastava, S.N. Pandey, A. Kumar, and B. Mittal Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population J Gastroenterol 44 2009 774 780
237. Y. Li, W. He, T. Liu, and Q. Zhang A new cyclo-oxygenase-2 gene variant in the Han Chinese population is associated with an increased risk of gastric carcinoma Mol Diag Ther 14 2010 351 355
238. K. Hur, S.H. Song, H.S. Lee, W. Ho Kim, Y.-J. Bang, and H.-K. Yang Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas Biochem Biophys Res Commun 310 2003 844 851
239. L. Huang, K.-L. Zhang, H. Li, X.-Y. Chen, Q.-Y. Kong, and Y. Sun Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian China. Hum Pathol 37 2006 1557 1567
240. M. Silva, D. Azenha, C. Pereira, A. Almeida, S. Balseiro, and A.M. Sampaio Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation Acta Med Port 23 2010 5 14
241. B.-C. Wang, C.-Q. Guo, C. Sun, Q.-L. Sun, G.-Y. Liu, and D.-G. Li Mechanism and clinical significance of cyclooxygenase-2 expression in gastric cancer World J Gastroenterol 11 2005 3240 3244
242. E. Amirian, Y. Liu, M.E. Scheurer, R. El-Zein, M.R. Gilbert, and M.L. Bondy Genetic variants in inflammation pathway genes and asthma in glioma susceptibility Neuro-oncology 12 2010 444 452
243. D. Campa, S. Zienolddiny, V. Maggini, V. Skaug, A. Haugen, and F. Canzian Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer Carcinogenesis 25 2004 229 235
244. H. Ben Nasr, K. Chahed, N. Bouaouina, and L. Chouchane PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma Mol Biol Rep 36 2009 193 200
245. M.G. Lira, S. Mazzola, G. Tessari, G. Malerba, M. Ortombina, and L. Naldi Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation Br J Dermatol 157 2007 49 57
246. G. Lurie, K.L. Terry, L.R. Wilkens, P.J. Thompson, K.E. McDuffie, and M.E. Carney Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk Cancer Causes Control 21 2010 1731 1741
247. Y.-W. Huang, R.A. Jansen, E. Fabbri, D. Potter, S. Liyanarachchi, and M.W.Y. Chan Identification of candidate epigenetic biomarkers for ovarian cancer detection Oncol Rep 22 2009 853 861
248. S.K. Huang, A.S. Fisher, A.M. Scruggs, E.S. White, C.M. Hogaboam, and B.C. Richardson Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice Am J Pathol 2010
249. B. Hoeft, J. Linseisen, L. Beckmann, K. Müller-Decker, F. Canzian, and A. Hüsing Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk Carcinogenesis 31 2010 466 472